Skip to main content
. 2020 Nov 11;10:548692. doi: 10.3389/fonc.2020.548692

Figure 2.

Figure 2

Kaplan–Meier survival curves for patients with and without tumor deposits (TDs) among all patients and pathological N (pN) stage patients. (A) All patients in the training cohort; (B) pN1a substage in the training cohort; (C) pN1b substage in the training cohort; (D) pN2a substage in the training cohort; (E) pN2b substage in the training cohort; (F) all patients in the validation cohort; (G) pN1a substage in the validation cohort; (H) pN1b substage in the validation cohort; (I) pN2a substage in the validation cohort; (J) pN2b substage in the validation cohort.